142685-25-4

Basic information

• Product Name: 2,3,5,6-TETRAFLUOROPHENYL TRIFLUOROACETATE
• Synonyms: 2,3,5,6-TETRAFLUOROPHENYL TRIFLUOROACETATE;2,3,5,6-Tetrafluorophenyl trifluoroacetate 98%;2,3,5,6-Tetrafluorophenyltrifluoroacetate98%;Trifluoroacetic acid 2,3,5,6-tetrafluorophenyl ester, 2,3,5,6-Tetrafluorophenyl 2,2,2-trifluoroethanoate;2,3,5,6-Tetrafluorophenyl 2,2,2-trifluoroacetate
• CAS NO: 142685-25-4
• Molecular Formula: C₈HF₇O₂
• Molecular Weight: 262.08
• Mol File: 142685-25-4.mol

Chemical Properties

• Boiling Point: 145.996°C at 760 mmHg
• Flash Point: 41.681°C
• Appearance: /
• Density: 1.635g/cm³
• Vapor Pressure: 4.734mmHg at 25°C
• Refractive Index: 1.39
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2,3,5,6-TETRAFLUOROPHENYL TRIFLUOROACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3,5,6-TETRAFLUOROPHENYL TRIFLUOROACETATE(142685-25-4)
• EPA Substance Registry System: 2,3,5,6-TETRAFLUOROPHENYL TRIFLUOROACETATE(142685-25-4)

Safety Data

• Hazard Codes: C
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 142685-25-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
2,3,5,6-TETRAFLUOROPHENYL TRIFLUOROACETATE is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new drugs and pesticides.
Used as a Solvent in Organic Reactions:
In the chemical industry, 2,3,5,6-TETRAFLUOROPHENYL TRIFLUOROACETATE serves as a solvent for organic reactions, facilitating specific chemical processes and improving the efficiency of certain syntheses.
Used as a Reagent in Fluorination Processes:
2,3,5,6-TETRAFLUOROPHENYL TRIFLUOROACETATE is utilized as a reagent in the fluorination of organic compounds, enabling the introduction of fluorine atoms into molecules, which can significantly alter their properties and reactivity.
Safety Note:
Due to its high reactivity, 2,3,5,6-TETRAFLUOROPHENYL TRIFLUOROACETATE should be handled with caution. It has the potential to cause skin and eye irritation, and appropriate safety measures should be taken during its use.

InChI:InChI=1/C8HF7O2/c9-2-1-3(10)5(12)6(4(2)11)17-7(16)8(13,14)15/h1H

Upstream product

• 769-39-1 2,3,5,6-tetraflourophenol 
• 407-25-0 trifluoroacetic anhydride 

Downstream Products

• 170962-90-0 2,3,5,6-tetrafluorophenyl 3-O-methyllithocholate 
• 199734-70-8 2,3,5,6-tetrafluorophenyl 2-(2-nitroimidazol-1-yl)acetate 
• 192657-33-3 C₃₄H₂₆F₄N₄O₅ 
• 380607-61-4 5-N-(tert-butyloxycarbonyl)aminoisophthalate-1,3-bis-O-(2,3,5,6-tetrafluorophenyl) ester 
• 173341-32-7 biotin 2,3,5,6-tetrafluorophenyl ester 
• 195152-91-1 3-(biotinamido)butyrate tetraflulorophenyl ester 
• 852178-14-4 2,3,5,6-tetrafluorophenoxycarbonylmethyl thiosulfate N,N-diisopropylethylamine salt 
• 852178-15-5 C₁₄H₁₄F₄NO₆S₂^(1-)*Na⁽¹⁺⁾ 

Relevant articles and documents

In situ monitoring of bindings between dasatinib and its target protein kinases using magnetic nanoparticles in live cells

We report a novel technology, called In Cell IT, for in situ monitoring of bindings between a small molecule kinase inhibitor and its target protein kinases in live cells using a kinase inhibitor, dasatinib, as a model compound. Streptavidin-attached MNPs were coated by biotinylated dasatinib, and then these dasatinib-MNPs were transferred into cells. In the cells, the MNPs were aligned to the same direction of the magnetic field and EGFP-tagged target protein kinases were bound to dasatinib-MNPs. Using this technology, we demonstrated the bindings between dasatinib and its target protein kinases including SRC, ABL1, and CSK in live cells. The specificity of these bindings was also confirmed by cold competition using unbiotinylated dasatinib in the same cells. Copyright

POLYBIOTIN COMPOUNDS FOR MAGNETIC RESONANCE IMAGINING AND DRUG DELIVERY

The invention relates generally to biotin-containing compounds that are useful as imaging agents and drug-delivery agents. Another aspect of the invention relates to the aforementioned compounds chelated to a metal atom. In a preferred embodiment, the metal atom is a gadolinium. Another aspect of the invention relates to a compound comprising three biotin moieties and a pharmaceutical agent covalently bound to a heterocyclic core. In certain embodiments, the pharmaceutical agent is an antibiotic, antiviral, or radionuclide. Another aspect of the present invention relates to a method of treating disease involving administering the compounds of the invention to a mammal. Another aspect of the present invention relates to a method of acquiring a magnetic resonance image using the compounds of the invention.

Bifunctional Crosslinking oligonucleotides adapted for linking to a target sequence of duplex DNA

Chemically modified oligonucleotides (ODNS) are complementary, either in the sense of the classic “four letter code” recognition motif, or in the sense required for triple strand formation based on the more limited “two letter code recognition motif”, to

Synthesis of [18F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia

[18F]-2-(2-Nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide ([18F]-EF3) has been prepared, in 65% chemical yield and 5% radiochemical yield, by coupling 2,3,5,6-tetrafluorophenyl 2-(2-nitroimidazol-1-yl) acetate 1 with [18F]-3,3,3-trifluoropropylamine 7. This original radiolabelled key-synthon was obtained in 40% overall chemical yield by oxidative [18F]-fluorodesulfurization of ethyl N-phthalimido-3-aminopropane dithioate 4, followed by deprotection with hydrazine of the resulting [18F]-N-phthalimido-3,3,3-trifluoropropylamine 5. All the process was performed within 90min, from the [18F]-HF production in the cyclotron to the purification of the final target. Copyright

Selective binding complementary oligonucleotides

In a matched pair of oligonucleotides (ODNS) each member of the pair is complementary or substantially complementary in the Watson Crick sense to a target sequence of duplex nucleic acid where the two strands of the target sequence are themselves compleme

Solid support for synthesis of 3'-tailed oligonucleotides

A solid support for oligonucleotide synthesis has the structure STR1 where CPG represents a controlled pore glass matrix, the wavy line represents a carbon chain covalently linking the NH group with the controlled pore glass matrix, X is 2,2'-dimethoxytri